Simvastatin Recruiting Phase 3 Trials for Secondary Progressive Multiple Sclerosis (SPMS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03387670Multiple Sclerosis-Simvastatin Trial 2